Becker's Healthcare April 3, 2024
Paige Twenter

The FDA has authorized the nation’s first AI-powered sepsis detection tool, artificial intelligence company Prenosis said April 3.

Clinicians have long been searching for — and testing — detection tools for sepsis, a life-threatening condition that at least 1.7 million adults in the U.S. develop each year. One in three patients who die in hospitals had sepsis during their stay, according to the CDC.

The authorized device is Sepsis Immunoscore, a machine learning software that integrates with hospital EHRs, according to a Prenosis news release. It uses 22 parameters to evaluate a patient’s biological status, calculate a sepsis risk score and four discrete risk categories, and display the results. The tool is not an alert system.

Many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article